SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $724,596 | +3.7% | 24,105 | +6.2% | 0.00% | 0.0% |
| Q2 2021 | $699,000 | -28.8% | 22,690 | -39.5% | 0.00% | -25.0% |
| Q1 2021 | $982,000 | +87.0% | 37,510 | +79.6% | 0.00% | +100.0% |
| Q4 2020 | $525,000 | +101.9% | 20,880 | +90.6% | 0.00% | +100.0% |
| Q2 2020 | $260,000 | +39.8% | 10,956 | +6.2% | 0.00% | 0.0% |
| Q1 2020 | $186,000 | -52.7% | 10,321 | -37.7% | 0.00% | -50.0% |
| Q4 2019 | $393,000 | -13.8% | 16,576 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $456,000 | -16.8% | 16,576 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $548,000 | -48.4% | 16,576 | -21.4% | 0.00% | -50.0% |
| Q3 2018 | $1,062,000 | -14.4% | 21,091 | +1.8% | 0.01% | -14.3% |
| Q2 2018 | $1,240,000 | +0.3% | 20,711 | -23.3% | 0.01% | 0.0% |
| Q1 2018 | $1,236,000 | +15.4% | 26,991 | +0.5% | 0.01% | +16.7% |
| Q4 2017 | $1,071,000 | +105.2% | 26,866 | +105.7% | 0.01% | +100.0% |
| Q3 2017 | $522,000 | – | 13,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |